Imeka: Taking you into the future of white matter research

Our imaging abilities are
powerful, unique, and non-invasive.

Imeka + you

Imeka’s
people

Collaborations

Webinars

IMEKA + YOU

Imeka: Because data means
nothing without analysis

Advanced white matter imaging—such as diffusion MRI (dMRI)—is a readily available technology that can pick up microstructural properties of the central nervous system. Data can be collected in as little as five minutes on a standard MRI machine.

It’s what you do with that data that makes all the difference.

Imeka’s ANIE (Advanced Neuro Imaging Endpoints) biomarker platform combines white matter imaging with artificial intelligence to analyze white matter MRI signals in greater detail than anyone else.

Learn more

How to collaborate with Imeka

The basic process is outlined below, but we adapt to your needs.
No matter how preliminary or advanced your project is, get in touch!

Our collaboration process

2

We discuss your project and confirm the scope of our collaboration.

4

We give you images and actionable answers based on the ANIE biomarker platform data analysis and our human knowledge and expertise.

IMEKA’S PEOPLE

The Imeka team is made of some of the most dedicated, driven, science-minded people you’ll ever meet.

EXECUTIVE TEAM

Collaborations

Our main goal is to play an influential role—and minimize risk—in the search for and development of cures for brain disease.

To achieve that, we collaborate broadly and deeply.

We work with everyone who cares about brain diseases, from privately owned and publicly traded companies to researchers, universities, MRI manufacturers, and investors.

Here are some of our ongoing collaborations:

Biopharmaceutical companies

We are ready and able to collaborate with biopharma companies in any country and at any clinical stage.

Clinical research organizations (CROs)

We offer our biopharma clients a seamless experience by partnering with preclinical and clinical CROs—including yours.

Investors

Imeka has received the support of many investors in the past 10 years—a testimony to our value.

Université de Sherbrooke (UdS)

Imeka co-founders Maxime Descoteaux and Pierre-Marc Jodoin are also professors who lead labs at the UdS.

Sherbrooke Connectivity Imaging Lab (SCIL)

We work closely with the SCIL and they with us; in essence the SCIL helps us develop state-of-the art methods and algorithms.

Academics and researchers

We have helped further groundbreaking research by collaborating with academics and researchers.

Want to collaborate?

Contact us

WEBINARS

We are always looking to advance research and spread knowledge. So as part of our collaboration efforts, we continue to produce webinars on diverse topics and approaches.

Want to register for our next webinar?
Contact us at [email protected]!

Contact us

All our webinars are available on our YouTube channel. Click a title to watch.

Alexa Pichet Binette, PhD, postdoctoral fellow at Lund University, Sweden

White Matter Microstructure and Alzheimer’s Disease Pathology: Insights from Tractography and PET Imaging

Guido Guberman, MD/PhD candidate at McGill University
Concussion Biomarkers: Novel Imaging and Advanced Statistics

Sami Obaid, MD, CM, FRCSC, Neurosurgeon, PhD candidate, University of Montreal

Utility of Tractography and Connectomics in Neurosurgery : Why Tracking Matters

Ann-Marie Beaudoin, MD, Neurology Department,
Centre hospitalier universitaire de Sherbrooke,
Université de Sherbrooke

Diffusion MRI in Multiple Sclerosis and Why it Matters

Tim Sinnecker, neurologist at the University Hospital of Basel, and postdoctoral researcher at the Medical Image Analysis Center (MIAC) in Basel, Switzerland

Quantitative MRI to Assess Tissue Damage in Multiple Sclerosis

Julien Cohen-Adad, PhD and Associate Professor, Polytechnique Montreal

MRI Biomarkers for the Spinal Cord

Pierre-Marc Jodoin, PhD, Imeka’s co-founder and Chief Artificial Intelligence Officer
AI: What’s Under the Hood? Why & How Does It Work?

See more

Let’s collaborate!

Like you, our main goal is to play an influential role—and minimize risk—in the search for and development of cures for brain diseases. Let’s see what we can do together.

Contact us